Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A well-designed cross-sectional study with biomarker-confirmed early AD and matched controls, demonstrating a mechanistic link between motor cortical hyperexcitability and cognitive impairment, but limited by cross-sectional design and lack of longitudinal or clinical outcome validation.
A real result from a sound but limited single-centre observational study with in vitro validation, identifying a biomarker with potential diagnostic utility that needs prospective validation.
This is a mechanistic cell and tissue study demonstrating that UBE2C knockdown suppresses pancreatic cancer cell behavior through PI3K/Akt/mTOR pathway inhibition, with reversal by pathway activator SC79, but lacks clinical trial data, human efficacy endpoints, or effect sizes with confidence intervals.
Mechanistic study in animal models and cell cultures with observational human data; identifies a putative pathway but lacks clinical outcome validation or human intervention trials needed for stronger evidence.